Join
Live feed
·
NEWSReleasevia Quantisnow
Akili Inc. logo

Akili Reports FDA Clearance Of EndeavorOTC (AKL-T01) As An Over-the-counter Treatment For Adults With Attention-deficit/Hyperactivity Disorder

ByQuantisnow·Wall Street's wire, on your screen.
AKLI· Akili Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AKLI (Akili Inc.) and more on Quantisnow.